Teva to face inhaler infringement allegations in UK court
03-06-2020
JHVEPhoto / Shutterstock.com
Israeli drug manufacturer Teva Pharmaceuticals is suing India-based Cipla to block the launch of generic Qvar (beclomethasone dipropionate) asthma inhalers.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, Cipla, generics, Qvar, asthma, inhaler, beclomethasone dipropionate, ANDA, OCA, patent, infringement
